Explore conditions GLP-1s may treat beyond weight loss, including FDA-approved uses for sleep apnea, cardiovascular and kidney disease.

GIP drugs such as tirzepatide (Mounjaro, Zepbound) are transforming metabolic health. Learn how they work, their uses, and ...

If you are diagnosed with Polyendocrine Metabolic Ovarian Syndrome, it doesn’t mean that you are destined to have poor health ...

Doctors say some people may be unaware they are experiencing symptoms of insulin resistance, however, it can be reversed with ...

Gestational diabetes affects an estimated 13–23 per cent of pregnant women in India and occurs when pregnancy-related ...

Brits who use weight loss jabs have been urged to “call 111” if they experience a potentially dangerous symptom. This could ...

Constipation linked to Ozempic can last around six weeks, and higher doses may increase the chances of digestive discomfort while the body adjusts to treatment.

While GLP-1s have, for years, been a prescribed treatment for type 2 diabetes, they now are an FDA-approved weight-loss drug that also reduce the risk of certain cancers, heart disease, cognitive ...

Researchers at the University of Chicago have discovered how the body defends itself against pancreatitis at the cellular ...

Weight-loss drugs such as Ozempic and Wegovy have already transformed the treatment of obesity and diabetes. Millions of ...

Identifying children with early signs of type 1 diabetes makes a difference to their health. A new study suggests wider screening is effective.